Register to get unlimited Level 2

Company Announcements

Director/PDMR Shareholding

Related Companies

By LSE RNS

RNS Number : 3073L
Circassia Pharmaceuticals Plc
17 July 2017
 

Persons Discharging Managerial Responsibilities / persons closely associated with them (PDMR) Notification

 

17 June 2017: Circassia Pharmaceuticals plc (LSE: CIR).

 

 

1 - Details of the person discharging managerial responsibilities/person closely associated

 

Name

Steven Harris

 

2 - Reason for the notification

 

Position/status 

Chief Executive Officer (PDMR)

Initial notification/amendment*

Initial Notification

In case of amendment, please enter the previous notification reference number and explain the error that this notification needs amending

N/A

 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

Full name of entity*

Circassia Pharmaceuticals plc

Legal Entity Identifier code

2138006YAT138TOGA556


In accordance with ISO 1744 LEI code

 

4 - Details of the transaction(s)

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

Date

Description of Financial Transaction

Aggregated Price

Aggregated Volume

Total Aggregated Price

17-Jun-17

Exercise of options under the 2007 EMI scheme without sale of shares (options issued under 2007 EMI scheme expire 10 years following grant)

£0.0008

535,375

£428.30

 

 

i.          Exercise of options

 

Description of the financial instrument, type of instrument

Circassia Holdings Ltd 2007 Unapproved Option Scheme

Identification Code

GB00BJVD3B28

Nature of the transaction

Exercise of options

Currency

GBP

Price(s) and Volume (s)

Price

Volume

Total

£0.0008p

535,375

£428.30

Aggregated Information

Price

Volume

Total

£0.0008p

535,375

£428.30

Date of Transaction

17 June 2017

Place of Transaction

London: XLON

 

 

For further information, please contact:

 

Circassia Pharmaceuticals plc

Julien Cotta, Company Secretary

 

+44 (0) 1865 405560

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBRGDRCBBBGRR

Top of Page